Research Grants to Rigorously Evaluate Innovative and Promising Approaches to Prevent Firearm-Related Violence and Injuries
Forecast
Centers for Disease Control and Prevention - ERA plans to offer grants of up to $650,000 to any type of organization. It expects to make about 12 awards worth $13.5 million in total. It is a forecast: the notice is expected around October 1, 2026, with applications due around December 1, 2026.
From the official notice on Grants.gov, last changed July 9, 2026. Checked October 31, 2026.
- Award ceiling$650,000
- Award floornot stated
- Expected awards12
- Total funding$13.5 million
- Cost sharingNot required
- Funding typeGrant
Key dates
| Forecast posted | July 9, 2026 |
|---|---|
| Expected posting | October 1, 2026 |
| Expected deadline | December 1, 2026 |
| Expected award date | August 28, 2027 |
Add the deadline to your calendar
Who can apply
This opportunity is open to any type of organization.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Faith Based OrganizationsAdditional Eligibility Information to be included in the NOFO
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC or the Injury Center) is soliciting investigator-initiated research to rigorously evaluate the effectiveness of innovative and promising approaches to prevent all forms of firearm-related injuries, deaths, violence, or crime without infringing on the rights of legal firearm owners. For this announcement such forms include: Mass shooting incidents, Defensive gun use incidents, Firearm-related homicides and assaults, Firearm-related suicides and self-harm, Unintentional firearm deaths and injuries, Firearm-related crime. This NOFO offers Funding Option A or B to address the research objective. Applicants may submit a research proposal under either Funding Option A or B (not both). Funding Option A will support research projects that rely on existing data to evaluate effectiveness and that do not support implementing prevention activities. These projects will be funded up to $350,000 per year (direct and indirect costs) for a period of performance up to 2 years. Funding Option B will support research projects that require new data collection and/or implementation of prevention activities to evaluate effectiveness. These projects will be funded up to $650,000 per year (direct and indirect costs) for a period of performance up to 3 years. Investigations could, for example, conduct research to evaluate the effectiveness and/or test the effects of scaling up, expanding, or improving approaches: 1) To prevent mass shooting incidents, suicide/self-harm firearm injuries, firearm-related assaults and homicides, unintentional firearm deaths and injuries, and firearm-related crime; 2) To study defensive gun use as a strategy for prevention of injuries, deaths, and crime 3) For different population groups (e.g., children, youth, young adults, active-duty military/veterans, rural communities, tribal populations, and those at risk of harming themselves or others, including in situations of family and intimate partner violence); 4) For different settings (e.g., rural/urban, home, school, neighborhood, community, online) that can be leveraged to prevent firearm-related injuries and crime; 5) For addressing various individual, peer/family, community and societal risk and protective factors including approaches that address the community factors that contribute to firearm-related injuries, violence, deaths, and crime.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Joyce Dieterly, ncipc_erpo@cdc.gov, 404-718-5301.
Questions people ask
Who can apply for Research Grants to Rigorously Evaluate Innovative and Promising Approaches to Prevent Firearm-Related Violence and Injuries?
Centers for Disease Control and Prevention - ERA accepts applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Research Grants to Rigorously Evaluate Innovative and Promising Approaches to Prevent Firearm-Related Violence and Injuries?
Expected deadline December 1, 2026. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
Awards of up to $650,000 each. About $13.5 million in total across about 12 awards.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience